These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 26313651)
1. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen. Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651 [TBL] [Abstract][Full Text] [Related]
2. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT). Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723 [TBL] [Abstract][Full Text] [Related]
3. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor. Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062 [TBL] [Abstract][Full Text] [Related]
4. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy. Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765 [TBL] [Abstract][Full Text] [Related]
5. Near infrared photoimmunotherapy with an anti-mesothelin antibody. Nagaya T; Nakamura Y; Sato K; Zhang YF; Ni M; Choyke PL; Ho M; Kobayashi H Oncotarget; 2016 Apr; 7(17):23361-9. PubMed ID: 26981775 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging. Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265 [TBL] [Abstract][Full Text] [Related]
7. Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer. Nakamura Y; Ohler ZW; Householder D; Nagaya T; Sato K; Okuyama S; Ogata F; Daar D; Hoa T; Choyke PL; Kobayashi H Mol Cancer Ther; 2017 Feb; 16(2):408-414. PubMed ID: 28151706 [TBL] [Abstract][Full Text] [Related]
8. Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody. Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H Mol Cancer Res; 2017 Sep; 15(9):1153-1162. PubMed ID: 28588059 [TBL] [Abstract][Full Text] [Related]
9. Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate. Nagaya T; Gorka AP; Nani RR; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Schnermann MJ; Kobayashi H Mol Cancer Ther; 2018 Mar; 17(3):661-670. PubMed ID: 29237807 [TBL] [Abstract][Full Text] [Related]
10. Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody. Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Hodge JW; Schlom J; Kobayashi H Oncotarget; 2017 Jan; 8(5):8807-8817. PubMed ID: 27716622 [TBL] [Abstract][Full Text] [Related]
11. Near infrared photoimmunotherapy using a fiber optic diffuser for treating peritoneal gastric cancer dissemination. Nagaya T; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H Gastric Cancer; 2019 May; 22(3):463-472. PubMed ID: 30171392 [TBL] [Abstract][Full Text] [Related]
12. Near infrared photoimmunotherapy of B-cell lymphoma. Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H Mol Oncol; 2016 Nov; 10(9):1404-1414. PubMed ID: 27511870 [TBL] [Abstract][Full Text] [Related]
13. Trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer. Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134 [TBL] [Abstract][Full Text] [Related]
14. Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy. Mitsunaga M; Nakajima T; Sano K; Kramer-Marek G; Choyke PL; Kobayashi H BMC Cancer; 2012 Aug; 12():345. PubMed ID: 22873679 [TBL] [Abstract][Full Text] [Related]
15. Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer. Ito K; Mitsunaga M; Nishimura T; Saruta M; Iwamoto T; Kobayashi H; Tajiri H Bioconjug Chem; 2017 May; 28(5):1458-1469. PubMed ID: 28402624 [TBL] [Abstract][Full Text] [Related]
16. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody. Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378 [TBL] [Abstract][Full Text] [Related]
17. Selective Photokilling of Colorectal Tumors by Near-Infrared Photoimmunotherapy with a GPA33-Targeted Single-Chain Antibody Variable Fragment Conjugate. Wei D; Tao Z; Shi Q; Wang L; Liu L; She T; Yi Q; Wen X; Liu L; Li S; Yang H; Jiang X Mol Pharm; 2020 Jul; 17(7):2508-2517. PubMed ID: 32396000 [TBL] [Abstract][Full Text] [Related]
19. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer. Harada T; Nakamura Y; Sato K; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H Oncotarget; 2016 Nov; 7(48):79408-79416. PubMed ID: 27765903 [TBL] [Abstract][Full Text] [Related]
20. Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers. Cui Y; Xu Y; Li Y; Sun Y; Hu J; Jia J; Li X Technol Cancer Res Treat; 2023; 22():15330338221145992. PubMed ID: 36734039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]